[Edaily Reporter Hyera Lee ] Curiosis Inc. is up by more than 15% in early trading. According to MP Doctor on the 15th, Curiosis Inc. is trading at 14,730 won as of 9:20 a.m. today, up 15.34% from the previous trading day. This is believed to be driven by news that Curiosis Inc. has signed a global supply contract with M, a German global biotech company, for automated cell imaging products. Curiosis Inc. previously announced that it signed the contract with Company M on the 12th, and that the supplied product is a new item based on the company’s live-cell imaging system, the “Celloger Mini Plus.” Under this agreement, M will supply the product to global markets under its own brand. The product is scheduled to be sold through “EMD Millipore,” M’s U.S.-based life sciences subsidiary. The contract term is five years, effective from the 7th, and will be automatically renewed on a yearly basis thereafter. Following its previous partnership with global life sciences company Revvity, Curiosis Inc. has now secured M as a new client.
The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…
